bioRxivBiophysics
Structural Mechanism Underlying Ligand Binding and Activation of PPARγ
Abstract
Ligands bind to an occluded orthosteric pocket within the nuclear receptor (NR) ligand-binding domain (LBD). Molecular simulations have revealed several theoretical ligand entry/exit pathways to the orthosteric pocket, but experimentally it remains unclear whether ligand binding proceeds through induced fit or conformational selection mechanisms. Using NMR spectroscopy lineshape analysis, we show that ligand binding to the peroxisome proliferator-activated receptor gamma (PPAR{gamma}) LBD involves a two-step induced fit mechanism including an initial fast step followed by slow conformational change. Surface plasmon resonance and isothermal titration calorimetry heat capacity analysis support the fast kinetic binding step and the conformational change after binding step, respectively. The putative initial ligand binding pose is suggested in several crystal structures of PPAR{gamma} LBD where a ligand is bound to a surface pore formed by helix 3, the {beta}-sheet, and the {Omega}-loop--one of several ligand entry sites suggested in previous targeted and unbiased molecular simulations. These findings, when considered with a recent NMR study showing the activation function-2 (AF-2) helix 12 exchanges in and out of the orthosteric pocket in apo/ligand-free PPAR{gamma}, suggest an activation mechanism whereby agonist binding occurs through an initial encounter complex with the LBD followed by transition of the ligand into the orthosteric pocket concomitant with a conformational change resulting in a solvent-exposed active helix 12 conformation.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cooperative Cobinding of Synthetic and Natural Ligands to the Nuclear Receptor PPARγ
J. Shang, R. Brust, … D. J. Kojetin·bioRxiv·Nov 1, 2018
- A structural mechanism for directing inverse agonism of PPARγ
R. Brust, J. Shang, … D. Kojetin·bioRxiv·Jan 17, 2018
- Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states
Brian S. MacTavish, Di Zhu, … Douglas J. Kojetin·Nature CommunicationsPeer-reviewed·Feb 28, 2025
- Shifting the PPARγ conformational ensemble towards a transcriptionally repressive state improves covalent inhibitor efficacy
Liudmyla Arifova, Brian S. MacTavish, … Douglas J. Kojetin·eLifePeer-reviewed·Jan 21, 2026
- Quantitative Structural Assessment of Graded Receptor Agonism
J. Shang, R. Brust, … D. Kojetin·bioRxiv·Apr 29, 2019
- Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARgamma
Jinsai Shang, Douglas J. Kojetin·eLifePeer-reviewed·Jul 18, 2024